The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles

Transfusion

Volumn 54, Issue 8, 2014, Pages 1917-1926

  Johnson, Lacey ^a   Coorey, Craig P ^a,b   Marks, Denese C ^a  

^a Research and Development   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLSERINE;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; CRYOPRESERVATION; FREEZE THAWING; HEMOSTASIS; HUMAN; PLATELET MICROPARTICLE; PROTEIN EXPRESSION; SUPERNATANT; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; THROMBOELASTOGRAPHY;

ACETATES; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; BLOOD PRESERVATION; CELL MEMBRANE; CELL-DERIVED MICROPARTICLES; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; GLUCOSE; HEMOSTASIS; HUMANS; INORGANIC CHEMICALS; MEMBRANE LIPIDS; PHOSPHATIDYLSERINES; PLASMA; PLATELET AGGREGATION; SOLUTIONS;

EID: 84906277580     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12578     Document Type: Article

References (42)

1. Schiffer CA, Aisner J, Wiernik PH,. Clinical experience with transfusion of cryopreserved platelets. Br J Haematol 1976; 34: 377-385.
2. Melaragno AJ, Carciero R, Feingold H, et al. Cryopreservation of human platelets using 6% dimethyl sulfoxide and storage at -80. Vox Sang 1985; 49: 245-258.
3. Valeri CR, Ragno G, Khuri S,. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80C without postthaw processing. Transfusion 2005; 45: 1890-1898.
4. Lelkens CC, Koning JG, De Kort B, et al. Experiences with frozen blood products in the Netherlands military. Transfus Apher Sci 2006; 34: 289-298.
5. Dumont LJ, Cancelas JA, Dumont DF, et al. A randomized controlled trial evaluating recovery and survival of 6% dimethyl sulfoxide-frozen autologous platelets in healthy volunteers. Transfusion 2013; 53: 128-137.
6. Johnson L, Reid S, Tan S, et al. PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion 2013; 53: 2268-2277.
7. Noorman F, Badloe J,. -80C frozen platelets, efficient logistics: available, compatible, safe and effective in the treatment of trauma patients with or without massive blood loss in military theatre. Transfusion 2012; 52 Suppl: 33A.
8. Johnson LN, Winter KM, Reid S, et al. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Cryobiology 2011; 62: 100-106.
9. Valeri CR, Macgregor H, Ragno G,. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension. Transfusion 2005; 45: 596-603.
10. Khuri S, Healey N, Macgregor H, et al. Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 117: 172-183.
11. Barnard MR, Macgregor H, Ragno G, et al. Fresh, liquid-preserved, and cryopreserved platelets: adhesive surface receptors and membrane procoagulant activity. Transfusion 1999; 39: 880-888.
12. Freyssinet JM, Toti F,. Formation of procoagulant microparticles and properties. Thromb Res 2010; 125 Suppl 1: S46-48.
13. Key NS,. Analysis of tissue factor positive microparticles. Thromb Res 2010; 125 (Suppl 1): S42-45.
14. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, et al. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006; 134: 307-313.
15. Matijevic N, Wang YW, Kostousov V, et al. Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res 2011; 128: 35-41.
16. Lawrie AS, Harrison P, Cardigan RA, et al. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008; 95: 197-204.
17. Owens AP, Mackman N,. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284-1297.
18. Siddiqui FA, Desai H, Amirkhosravi A, et al. The presence and release of tissue factor from human platelets. Platelets 2002; 13: 247-253.
19. Blair P, Flaumenhaft R,. Platelet α-granules: basic biology and clinical correlates. Blood Rev 2009; 23: 177-189.
20. Devine D, Serrano K, Levin E, et al. Flow cytometric detection and characterisation of platelet microparticles in platelet concentrates at expiry. Vox Sang 2012; 103: 124.
21. Exner T, Joseph J, Low J, et al. A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis 2003; 14: 773-779.
22. Valeri CR, Srey R, Tilahun D, et al. In vitro effects of poly-n-acetyl glucosamine on the activation of platelets in platelet-rich plasma with and without red blood cells. J Trauma 2004; 57: S22-25.
23. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
24. Hellum M, Øvstebø R, Trøseid A, et al. Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay. Blood Coagul Fibrinolysis 2012; 23: 520-526.
25. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434.
26. Nollet KE, Saito S, Ono T, et al. Microparticle formation in apheresis platelets is not affected by three leukoreduction filters. Transfusion 2013; 53: 2293-2298.
27. Ostrowski SR, Sørensen AM, Larsen CF, et al. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med 2011; 19: 3-10.
28. Al Dieri R, De Laat B, Hemker HC,. Thrombin generation: what have we learned? Blood Rev 2012; 26: 197-203.
29. Harr JN, Moore EE, Ghasabyan A, et al. Funtional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock 2013; 39: 45-49.
30. Bowbrick VA, Mikhailidis DP, Stansby G,. Value of thromboelastography in the assessment of platelet function. Clin Appl Thromb Hemost 2003; 9: 137-142.
31. Macey MG, Enniks N, Bevan S,. Flow cytometric analysis of microparticle phenotype and their role in thrombin generation. Cytometry B Clin Cytom 2011; 80B: 57-63.
32. Mayne E, Funderburg NT, Sieg SF, et al. Increased platelet and microparticle activation in HIV infection: upregulation of p-selectin and tissue factor expression. J Acquir Immune Defic Syndr 2012; 59: 340-346.
33. Hornsey VS, McMillan L, Morrison A, et al. Freezing of buffy coat-derived, leukoreduced platelet concentrates in 6 percent dimethyl sulfoxide. Transfusion 2008; 48: 2508-2514.
34. Berckmans RJ, Nieuwland R, Böing AN, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-646.
35. Valeri CR, Giorgio A, Macgregor H, et al. Circulation and distribution of autotransfused fresh, liquid-preserved and cryopreserved baboon platelets. Vox Sang 2002; 83: 347-351.
36. Holme S, Sweeney JD, Sawyer S, et al. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997; 37: 12-17.
37. Rumjantseva V, Hoffmeister KM,. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci 2010; 42: 63-70.
38. Badloe J, Noorman F,. The Netherlands experience with frozen -80C red cells, plasma and platelets in combat casualty care. Transfusion 2011; 51 Suppl: 24A.
39. Shah N, Northup P, Caldwell S,. A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol 2012; 11: 686-690.
40. Falanga A, Marchetti M, Russo L,. Venous thromboembolism in the hematologic malignancies. Curr Opin Oncol 2012; 24: 702-710.
41. Khorana A, Francis CW, Blumberg N, et al. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med 2008; 168: 2377-2381.
42. Van Doormaal F, Kleinjan A, Berckmans RJ, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients: an exploratory prospective study. Thromb Haemost 2012; 108: 160-165.